Our results clearly showed that nTreg and tumor-derived γδ Treg cells have a significantly higher glucose uptake than control naive CD4+ and CD8+ T cells, as well as CD4+CD25− effector T cells (Fig. 3b). The gene discussed is CD8A; the disease is neoplasm.